Financial Survey: Greenbrook TMS (GBNH) and Its Competitors

Greenbrook TMS (NASDAQ: GBNH) is one of 28 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it compare to its rivals? We will compare Greenbrook TMS to related companies based on the strength of its valuation, risk, earnings, profitability, analyst recommendations, dividends and institutional ownership.

Analyst Ratings

This is a breakdown of current ratings and price targets for Greenbrook TMS and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenbrook TMS 0 0 3 0 3.00
Greenbrook TMS Competitors 93 397 550 15 2.46

Greenbrook TMS currently has a consensus target price of $16.13, suggesting a potential upside of 34.94%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 22.03%. Given Greenbrook TMS’s stronger consensus rating and higher possible upside, analysts clearly believe Greenbrook TMS is more favorable than its rivals.

Valuation & Earnings

This table compares Greenbrook TMS and its rivals top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Greenbrook TMS $43.13 million -$29.66 million -5.15
Greenbrook TMS Competitors $1.90 billion $87.95 million 35.03

Greenbrook TMS’s rivals have higher revenue and earnings than Greenbrook TMS. Greenbrook TMS is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Greenbrook TMS and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Greenbrook TMS N/A N/A N/A
Greenbrook TMS Competitors -39.07% -3.98% -9.95%

Insider and Institutional Ownership

0.8% of Greenbrook TMS shares are owned by institutional investors. Comparatively, 43.7% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by institutional investors. 24.7% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

About Greenbrook TMS

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with MarketBeat.com's FREE daily email newsletter.